Launch
Website-
Not Fee assured
-
Awaiting
verification
- Open Referral network
Offers
- Face-to-face consultations
- Home chemotherapy
About me
Professor Paul Lorigan graduated from Trinity College, University of Dublin in 1986.
Extensive clinical and research experience of haematology and oncology was gained during subsequent posts. In 1996 Prof. Lorigan was appointed as Honorary Consultant and Senior Lecturer in Medical Oncology at The University of Sheffield and Weston Park Hospital. In 2002 he was appointed as an Honorary Consultant at The Christie Hospital and Senior Lecturer at Manchester University, Reader in 2013 and Professor in 2016.
He was Chair Elect (2013 until 2019) of Melanoma Focus, the UK national charity dedicated to research, treatment, education and information for clinical teams treating melanoma patients, for patients and their families. Previously he chaired the UK NCRI Melanoma Clinical Studies Group from 2006 to 2012 transforming it from failing to successful, and is Secretary of the EORTC Melanoma Group and member of a number of other research groups. Prof. Lorigan has been involved in a number of other projects. He was expert advisor to NICE in the Single Technology Appraisals (STA) of both ipilimumab and vemurafenib, and is a member of the Melanoma Forum. He also acts in the advisory capacity to many national and international groups.
Areas of interest
Melanoma
Medical secretaries
- Debbie Barlow
- 0161 446 3472
- deborah.barlow@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
The Christie Clinic (>50)
-
X0005
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (1-5)
The Christie Clinic (1-5)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)
The Christie Clinic (1-5)